HRP20211326T1 - Novi spojevi tetrazola i njihova primjena u liječenju tuberkuloze - Google Patents
Novi spojevi tetrazola i njihova primjena u liječenju tuberkuloze Download PDFInfo
- Publication number
- HRP20211326T1 HRP20211326T1 HRP20211326TT HRP20211326T HRP20211326T1 HR P20211326 T1 HRP20211326 T1 HR P20211326T1 HR P20211326T T HRP20211326T T HR P20211326TT HR P20211326 T HRP20211326 T HR P20211326T HR P20211326 T1 HRP20211326 T1 HR P20211326T1
- Authority
- HR
- Croatia
- Prior art keywords
- tetrazol
- benzenesulfonamide
- hydroxyethyl
- methyl
- ylmethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
- C07D249/06—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17382574 | 2017-08-17 | ||
| EP18755815.0A EP3668856B1 (en) | 2017-08-17 | 2018-08-16 | Novel tetrazole compounds and their use in the treatment of tuberculosis |
| PCT/EP2018/072205 WO2019034729A1 (en) | 2017-08-17 | 2018-08-16 | NOVEL TETRAZOLE COMPOUNDS AND THEIR USE IN THE TREATMENT OF TUBERCULOSIS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20211326T1 true HRP20211326T1 (hr) | 2021-11-26 |
Family
ID=59713960
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20211326TT HRP20211326T1 (hr) | 2017-08-17 | 2018-08-16 | Novi spojevi tetrazola i njihova primjena u liječenju tuberkuloze |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US11072591B2 (https=) |
| EP (1) | EP3668856B1 (https=) |
| JP (1) | JP7410017B2 (https=) |
| KR (1) | KR102661367B1 (https=) |
| CN (1) | CN110997651B (https=) |
| AU (1) | AU2018317812C1 (https=) |
| CA (1) | CA3072854A1 (https=) |
| CY (1) | CY1124577T1 (https=) |
| DK (1) | DK3668856T3 (https=) |
| ES (1) | ES2885573T3 (https=) |
| HR (1) | HRP20211326T1 (https=) |
| HU (1) | HUE055732T2 (https=) |
| LT (1) | LT3668856T (https=) |
| PL (1) | PL3668856T3 (https=) |
| PT (1) | PT3668856T (https=) |
| RS (1) | RS62267B1 (https=) |
| SI (1) | SI3668856T1 (https=) |
| SM (1) | SMT202100515T1 (https=) |
| WO (1) | WO2019034729A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111184718A (zh) * | 2018-11-15 | 2020-05-22 | 鲁南制药集团股份有限公司 | 法罗培南在制备治疗初治病原学阳性肺结核药物中的用途 |
| CN115403533B (zh) * | 2021-05-28 | 2023-08-25 | 永康市第一人民医院 | 一种1-苯乙烯基-1,2,3-三氮唑化合物及其制备方法和应用 |
| CN116102483B (zh) * | 2021-11-09 | 2025-01-17 | 中国医学科学院药物研究所 | 取代吡咯-2,5-二酮类化合物及其制备方法和用途 |
| CN116726018A (zh) * | 2023-08-02 | 2023-09-12 | 上海市肺科医院（上海市职业病防治院） | 一种贝达喹啉、德拉马尼、氯法齐明和吡嗪酰胺的联用和应用 |
| CN117379430A (zh) * | 2023-10-11 | 2024-01-12 | 深圳市第三人民医院(深圳市肝病研究所) | 一种地拉韦啶的用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3621427B2 (ja) | 1997-07-22 | 2005-02-16 | 塩野義製薬株式会社 | 糸球体障害治療または予防剤 |
| KR20120003499A (ko) * | 2007-04-05 | 2012-01-10 | 지멘스 메디컬 솔루션즈 유에스에이, 인크. | 클릭 화학을 이용한 탄산탈수효소―ⅰⅹ에 대한 분자 영상화 프로브의 제조 |
| WO2017066964A1 (en) | 2015-10-22 | 2017-04-27 | Merck Sharp & Dohme Corp. | Oxazolidinone compounds and methods of use thereof as antibacterial agents |
-
2018
- 2018-08-16 WO PCT/EP2018/072205 patent/WO2019034729A1/en not_active Ceased
- 2018-08-16 ES ES18755815T patent/ES2885573T3/es active Active
- 2018-08-16 HR HRP20211326TT patent/HRP20211326T1/hr unknown
- 2018-08-16 US US16/639,163 patent/US11072591B2/en active Active
- 2018-08-16 PT PT187558150T patent/PT3668856T/pt unknown
- 2018-08-16 JP JP2020508427A patent/JP7410017B2/ja active Active
- 2018-08-16 SM SM20210515T patent/SMT202100515T1/it unknown
- 2018-08-16 EP EP18755815.0A patent/EP3668856B1/en active Active
- 2018-08-16 CN CN201880053320.XA patent/CN110997651B/zh active Active
- 2018-08-16 CA CA3072854A patent/CA3072854A1/en active Pending
- 2018-08-16 LT LTEPPCT/EP2018/072205T patent/LT3668856T/lt unknown
- 2018-08-16 SI SI201830348T patent/SI3668856T1/sl unknown
- 2018-08-16 PL PL18755815T patent/PL3668856T3/pl unknown
- 2018-08-16 RS RS20211076A patent/RS62267B1/sr unknown
- 2018-08-16 AU AU2018317812A patent/AU2018317812C1/en active Active
- 2018-08-16 KR KR1020207007186A patent/KR102661367B1/ko active Active
- 2018-08-16 DK DK18755815.0T patent/DK3668856T3/da active
- 2018-08-16 HU HUE18755815A patent/HUE055732T2/hu unknown
-
2021
- 2021-08-31 CY CY20211100770T patent/CY1124577T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3668856B1 (en) | 2021-06-23 |
| WO2019034729A1 (en) | 2019-02-21 |
| BR112020003247A2 (pt) | 2020-08-18 |
| JP2020531425A (ja) | 2020-11-05 |
| CA3072854A1 (en) | 2019-02-21 |
| ES2885573T3 (es) | 2021-12-14 |
| CN110997651A (zh) | 2020-04-10 |
| SMT202100515T1 (it) | 2021-11-12 |
| PL3668856T3 (pl) | 2021-12-13 |
| CY1124577T1 (el) | 2022-07-22 |
| RU2020110818A (ru) | 2021-09-17 |
| EP3668856A1 (en) | 2020-06-24 |
| US20200231555A1 (en) | 2020-07-23 |
| RS62267B1 (sr) | 2021-09-30 |
| US11072591B2 (en) | 2021-07-27 |
| KR20200041915A (ko) | 2020-04-22 |
| JP7410017B2 (ja) | 2024-01-09 |
| CN110997651B (zh) | 2023-01-03 |
| PT3668856T (pt) | 2021-09-15 |
| AU2018317812B2 (en) | 2021-04-15 |
| DK3668856T3 (da) | 2021-09-20 |
| HUE055732T2 (hu) | 2021-12-28 |
| RU2020110818A3 (https=) | 2021-10-11 |
| AU2018317812A1 (en) | 2020-02-20 |
| AU2018317812C1 (en) | 2021-08-26 |
| KR102661367B1 (ko) | 2024-04-29 |
| SI3668856T1 (sl) | 2021-11-30 |
| LT3668856T (lt) | 2021-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20211326T1 (hr) | Novi spojevi tetrazola i njihova primjena u liječenju tuberkuloze | |
| JP7330312B2 (ja) | Ｈｉｖを治療するためのトール様受容体の調節因子 | |
| JP2020531425A5 (https=) | ||
| US11352329B2 (en) | HIV protease inhibitors | |
| NZ716350A (en) | Tricyclic benzoxaborole compounds and uses thereof | |
| CN106749272B (zh) | 用于抗病毒治疗的2’-取代的卡巴-核苷类似物 | |
| JP2015501845A5 (https=) | ||
| ME02570B (me) | Farmaceutska kompozicija koja sadrži ne-nukleozidni inhibitor reverzne transkriptaze | |
| RU2006137555A (ru) | Способы и композиции для лечения вич-инфекции | |
| MX2020014163A (es) | Formas solidas y formulaciones de (s)-4-(8-amino-3-(1-(but-2-inoil )pirrolidin-2-il)imidazo [1,5-a]pirazin-1-il)-n-(piridin-2-il)benz amida. | |
| JP2016527321A5 (https=) | ||
| JP2017516797A (ja) | 組み合わせ | |
| JP2019511542A5 (https=) | ||
| HRP20211172T1 (hr) | Derivati kinolina za uporabu u liječenju ili prevenciji virusne infekcije | |
| AU2019270394A1 (en) | Substituted condensed thiophenes as modulators of sting | |
| IL272562B2 (en) | Compounds or pharmaceutically acceptable salts thereof for the treatment of mycobacterial infection | |
| US20180296505A1 (en) | Booster drug therapy for mycobacterium infections | |
| HRP20201780T1 (hr) | Prolijekovi inhibitora hiv reverzne transkriptaze | |
| HRP20201597T1 (hr) | 4-supstituirani spojevi benzoksaborola i njihova upotreba | |
| JP2020519592A5 (https=) | ||
| HRP20211894T1 (hr) | Novi spojevi | |
| RU2020110521A (ru) | Новые соединения | |
| Meyer et al. | Inhalative vaccination with pneumococcal polysaccharide in patients with chronic obstructive pulmonary disease | |
| CN113214262B (zh) | 一种含有胍基的化合物及其制备方法和用途 | |
| EP4387977A1 (en) | Phospholipid compounds and methods of making and using the same |